Search Legislation

Commission Implementing Regulation (EU) 2016/313Show full title

Commission Implementing Regulation (EU) 2016/313 of 1 March 2016 amending Implementing Regulation (EU) No 680/2014 with regard to additional monitoring metrics for liquidity reporting (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes over time for: Commission Implementing Regulation (EU) 2016/313 (Annexes only)

 Help about opening options

Status:

Point in time view as at 31/12/2020.

Changes to legislation:

Commission Implementing Regulation (EU) 2016/313 is up to date with all changes known to be in force on or before 07 November 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.

ANNEXU.K.

ANNEX XVIII ADDITIONAL LIQUIDITY MONITORING METRICS UNDER ARTICLE 415(3)(b) OF REGULATION (EU) No 575/2013

ALMM TEMPLATES
Template number Template code Name of the template/group of templates
ADDITIONAL MONITORING TOOLS TEMPLATES
67C 67.00CONCENTRATION OF FUNDING BY COUNTERPARTY
68C 68.00CONCENTRATION OF FUNDING BY PRODUCT TYPE
69C 69.00PRICES FOR VARIOUS LENGTHS OF FUNDING
70C 70.00ROLL-OVER OF FUNDING

C 67.00 — CONCENTRATION OF FUNDING BY COUNTERPARTY

z-axisTotal and significant currencies

Concentration of funding by counterparty
Counterparty Name LEI Code Counterparty Sector Residence of Counterparty Product Type Amount Received Weighted average initial maturity Weighted average residual maturity
Row ID010020030040050060070080
010
1. TOP TEN COUNTERPARTIES EACH GREATER THAN 1 % OF TOTAL LIABILITIES
0201,01
0301,02
0401,03
0501,04
0601,05
0701,06
0801,07
0901,08
1001,09
1101,10
120
2. ALL OTHER LIABILITIES

C 68.00 — CONCENTRATION OF FUNDING BY PRODUCT TYPE

z-axisTotal and significant currencies

Concentration of funding by product type
Row ID Product Name Total amount received Amount covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country Amount not covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country Weighted average initial maturity Weighted average residual maturity
010020030040050
PRODUCTS GREATER THAN 1 % OF TOTAL LIABILITIES
0101 RETAIL FUNDING
0201,1Sight deposits
0301,2Fixed term deposits with an initial maturity less than 30 days
0401,3Fixed term deposits with an initial maturity greater than 30 days
0501.3.1with a penalty for early withdrawal that is materially greater than losing the interest that would be obtained for the remaining maturity
0601.3.2without a penalty for early withdrawal that is materially greater than losing the interest that would be obtained for the remaining maturity
0701,4Savings accounts
0801.4.1with a notice period for withdrawal greater than 30 days
0901.4.2without a notice period for withdrawal greater than 30 days
1002 WHOLESALE FUNDING
1102,1Unsecured wholesale funding
1202.1.1of which financial customers
1302.1.2of which non-financial customers
1402.1.3of which from intra-group entities
1502,2Secured wholesale funding
1602.2.1of which repurchase agreements
1702.2.2of which covered bond issuance
1802.2.3of which asset backed security issuance
1902.2.4of which from intra-group entities

C 69.00 — PRICES FOR VARIOUS LENGTHS OF FUNDING

z-axisTotal and significant currencies

Prices for various lengths of funding
Overnight 1 week 1 month 3 months 6 months 1 year 2 years 5 years 10 years
Spread Volume Spread Volume Spread Volume Spread Volume Spread Volume Spread Volume Spread Volume Spread Volume Spread Volume
Row ID Item010020030040050060070080090100110120130140150160170180
0101 Total Funding
0201,1of which: Retail deposits
0301,2of which: Unsecured wholesale deposits
0401,3of which: Secured funding
0501,4of which: Senior unsecured securities
0601,5of which: Covered bonds
0701,6of which: Asset backed securities including ABCP

C 70.00 - ROLL-OVER OF FUNDING

z-axisTotal and significant currencies

Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
0101.1 1 Total funding
0201.1.1 Retail deposits
0301.1.2 Unsecured wholesale deposits
0401.1.3 Secured funding
0501.2 2 Total funding
0601.2.1 Retail deposits
0701.2.2 Unsecured wholesale deposits
0801.2.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
0101.1 1 Total funding
0201.1.1 Retail deposits
0301.1.2 Unsecured wholesale deposits
0401.1.3 Secured funding
0501.2 2 Total funding
0601.2.1 Retail deposits
0701.2.2 Unsecured wholesale deposits
0801.2.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
0101.1 1 Total funding
0201.1.1 Retail deposits
0301.1.2 Unsecured wholesale deposits
0401.1.3 Secured funding
0501.2 2 Total funding
0601.2.1 Retail deposits
0701.2.2 Unsecured wholesale deposits
0801.2.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
0901.3 3 Total funding
1001.3.1 Retail deposits
1101.3.2 Unsecured wholesale deposits
1201.3.3 Secured funding
1301.4 4 Total funding
1401.4.1 Retail deposits
1501.4.2 Unsecured wholesale deposits
1601.4.3 Secured funding
1701.5 5 Total funding
1801.5.1 Retail deposits
1901.5.2 Unsecured wholesale deposits
2001.5.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
0901.3 3 Total funding
1001.3.1 Retail deposits
1101.3.2 Unsecured wholesale deposits
1201.3.3 Secured funding
1301.4 4 Total funding
1401.4.1 Retail deposits
1501.4.2 Unsecured wholesale deposits
1601.4.3 Secured funding
1701.5 5 Total funding
1801.5.1 Retail deposits
1901.5.2 Unsecured wholesale deposits
2001.5.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
0901.3 3 Total funding
1001.3.1 Retail deposits
1101.3.2 Unsecured wholesale deposits
1201.3.3 Secured funding
1301.4 4 Total funding
1401.4.1 Retail deposits
1501.4.2 Unsecured wholesale deposits
1601.4.3 Secured funding
1701.5 5 Total funding
1801.5.1 Retail deposits
1901.5.2 Unsecured wholesale deposits
2001.5.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
2101.6 6 Total funding
2201.6.1 Retail deposits
2301.6.2 Unsecured wholesale deposits
2401.6.3 Secured funding
2501.7 7 Total funding
2601.7.1 Retail deposits
2701.7.2 Unsecured wholesale deposits
2801.7.3 Secured funding
2901.8 8 Total funding
3001.8.1 Retail deposits
3101.8.2 Unsecured wholesale deposits
3201.8.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
2101.6 6 Total funding
2201.6.1 Retail deposits
2301.6.2 Unsecured wholesale deposits
2401.6.3 Secured funding
2501.7 7 Total funding
2601.7.1 Retail deposits
2701.7.2 Unsecured wholesale deposits
2801.7.3 Secured funding
2901.8 8 Total funding
3001.8.1 Retail deposits
3101.8.2 Unsecured wholesale deposits
3201.8.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
2101.6 6 Total funding
2201.6.1 Retail deposits
2301.6.2 Unsecured wholesale deposits
2401.6.3 Secured funding
2501.7 7 Total funding
2601.7.1 Retail deposits
2701.7.2 Unsecured wholesale deposits
2801.7.3 Secured funding
2901.8 8 Total funding
3001.8.1 Retail deposits
3101.8.2 Unsecured wholesale deposits
3201.8.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
3301.9 9 Total funding
3401.9.1 Retail deposits
3501.9.2 Unsecured wholesale deposits
3601.9.3 Secured funding
3701.10 10 Total funding
3801.10.1 Retail deposits
3901.10.2 Unsecured wholesale deposits
4001.10.3 Secured funding
4101.11 11 Total funding
4201.11.1 Retail deposits
4301.11.2 Unsecured wholesale deposits
4401.11.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
3301.9 9 Total funding
3401.9.1 Retail deposits
3501.9.2 Unsecured wholesale deposits
3601.9.3 Secured funding
3701.10 10 Total funding
3801.10.1 Retail deposits
3901.10.2 Unsecured wholesale deposits
4001.10.3 Secured funding
4101.11 11 Total funding
4201.11.1 Retail deposits
4301.11.2 Unsecured wholesale deposits
4401.11.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
3301.9 9 Total funding
3401.9.1 Retail deposits
3501.9.2 Unsecured wholesale deposits
3601.9.3 Secured funding
3701.10 10 Total funding
3801.10.1 Retail deposits
3901.10.2 Unsecured wholesale deposits
4001.10.3 Secured funding
4101.11 11 Total funding
4201.11.1 Retail deposits
4301.11.2 Unsecured wholesale deposits
4401.11.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
4501.12 12 Total funding
4601.12.1 Retail deposits
4701.12.2 Unsecured wholesale deposits
4801.12.3 Secured funding
4901.13 13 Total funding
5001.13.1 Retail deposits
5101.13.2 Unsecured wholesale deposits
5201.13.3 Secured funding
5301.14 14 Total funding
5401.14.1 Retail deposits
5501.14.2 Unsecured wholesale deposits
5601.14.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
4501.12 12 Total funding
4601.12.1 Retail deposits
4701.12.2 Unsecured wholesale deposits
4801.12.3 Secured funding
4901.13 13 Total funding
5001.13.1 Retail deposits
5101.13.2 Unsecured wholesale deposits
5201.13.3 Secured funding
5301.14 14 Total funding
5401.14.1 Retail deposits
5501.14.2 Unsecured wholesale deposits
5601.14.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
4501.12 12 Total funding
4601.12.1 Retail deposits
4701.12.2 Unsecured wholesale deposits
4801.12.3 Secured funding
4901.13 13 Total funding
5001.13.1 Retail deposits
5101.13.2 Unsecured wholesale deposits
5201.13.3 Secured funding
5301.14 14 Total funding
5401.14.1 Retail deposits
5501.14.2 Unsecured wholesale deposits
5601.14.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
5701.15 15 Total funding
5801.15.1 Retail deposits
5901.15.2 Unsecured wholesale deposits
6001.15.3 Secured funding
6101.16 16 Total funding
6201.16.1 Retail deposits
6301.16.2 Unsecured wholesale deposits
6401.16.3 Secured funding
6501.17 17 Total funding
6601.17.1 Retail deposits
6701.17.2 Unsecured wholesale deposits
6801.17.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
5701.15 15 Total funding
5801.15.1 Retail deposits
5901.15.2 Unsecured wholesale deposits
6001.15.3 Secured funding
6101.16 16 Total funding
6201.16.1 Retail deposits
6301.16.2 Unsecured wholesale deposits
6401.16.3 Secured funding
6501.17 17 Total funding
6601.17.1 Retail deposits
6701.17.2 Unsecured wholesale deposits
6801.17.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
5701.15 15 Total funding
5801.15.1 Retail deposits
5901.15.2 Unsecured wholesale deposits
6001.15.3 Secured funding
6101.16 16 Total funding
6201.16.1 Retail deposits
6301.16.2 Unsecured wholesale deposits
6401.16.3 Secured funding
6501.17 17 Total funding
6601.17.1 Retail deposits
6701.17.2 Unsecured wholesale deposits
6801.17.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
6901.18 18 Total funding
7001.18.1 Retail deposits
7101.18.2 Unsecured wholesale deposits
7201.18.3 Secured funding
7301.19 19 Total funding
7401.19.1 Retail deposits
7501.19.2 Unsecured wholesale deposits
7601.19.3 Secured funding
7701.20 20 Total funding
7801.20.1 Retail deposits
7901.20.2 Unsecured wholesale deposits
8001.20.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
6901.18 18 Total funding
7001.18.1 Retail deposits
7101.18.2 Unsecured wholesale deposits
7201.18.3 Secured funding
7301.19 19 Total funding
7401.19.1 Retail deposits
7501.19.2 Unsecured wholesale deposits
7601.19.3 Secured funding
7701.20 20 Total funding
7801.20.1 Retail deposits
7901.20.2 Unsecured wholesale deposits
8001.20.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
6901.18 18 Total funding
7001.18.1 Retail deposits
7101.18.2 Unsecured wholesale deposits
7201.18.3 Secured funding
7301.19 19 Total funding
7401.19.1 Retail deposits
7501.19.2 Unsecured wholesale deposits
7601.19.3 Secured funding
7701.20 20 Total funding
7801.20.1 Retail deposits
7901.20.2 Unsecured wholesale deposits
8001.20.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
8101.21 21 Total funding
8201.21.1 Retail deposits
8301.21.2 Unsecured wholesale deposits
8401.21.3 Secured funding
8501.22 22 Total funding
8601.22.1 Retail deposits
8701.22.2 Unsecured wholesale deposits
8801.22.3 Secured funding
8901.23 23 Total funding
9001.23.1 Retail deposits
9101.23.2 Unsecured wholesale deposits
9201.23.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
8101.21 21 Total funding
8201.21.1 Retail deposits
8301.21.2 Unsecured wholesale deposits
8401.21.3 Secured funding
8501.22 22 Total funding
8601.22.1 Retail deposits
8701.22.2 Unsecured wholesale deposits
8801.22.3 Secured funding
8901.23 23 Total funding
9001.23.1 Retail deposits
9101.23.2 Unsecured wholesale deposits
9201.23.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
8101.21 21 Total funding
8201.21.1 Retail deposits
8301.21.2 Unsecured wholesale deposits
8401.21.3 Secured funding
8501.22 22 Total funding
8601.22.1 Retail deposits
8701.22.2 Unsecured wholesale deposits
8801.22.3 Secured funding
8901.23 23 Total funding
9001.23.1 Retail deposits
9101.23.2 Unsecured wholesale deposits
9201.23.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
9301.24 24 Total funding
9401.24.1 Retail deposits
9501.24.2 Unsecured wholesale deposits
9601.24.3 Secured funding
9701.25 25 Total funding
9801.25.1 Retail deposits
9901.25.2 Unsecured wholesale deposits
10001.25.3 Secured funding
10101.26 26 Total funding
10201.26.1 Retail deposits
10301.26.2 Unsecured wholesale deposits
10401.26.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
9301.24 24 Total funding
9401.24.1 Retail deposits
9501.24.2 Unsecured wholesale deposits
9601.24.3 Secured funding
9701.25 25 Total funding
9801.25.1 Retail deposits
9901.25.2 Unsecured wholesale deposits
10001.25.3 Secured funding
10101.26 26 Total funding
10201.26.1 Retail deposits
10301.26.2 Unsecured wholesale deposits
10401.26.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
9301.24 24 Total funding
9401.24.1 Retail deposits
9501.24.2 Unsecured wholesale deposits
9601.24.3 Secured funding
9701.25 25 Total funding
9801.25.1 Retail deposits
9901.25.2 Unsecured wholesale deposits
10001.25.3 Secured funding
10101.26 26 Total funding
10201.26.1 Retail deposits
10301.26.2 Unsecured wholesale deposits
10401.26.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
10501.27 27 Total funding
10601.27.1 Retail deposits
10701.27.2 Unsecured wholesale deposits
10801.27.3 Secured funding
10901.28 28 Total funding
11001.28.1 Retail deposits
11101.28.2 Unsecured wholesale deposits
11201.28.3 Secured funding
11301.29 29 Total funding
11401.29.1 Retail deposits
11501.29.2 Unsecured wholesale deposits
11601.29.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
10501.27 27 Total funding
10601.27.1 Retail deposits
10701.27.2 Unsecured wholesale deposits
10801.27.3 Secured funding
10901.28 28 Total funding
11001.28.1 Retail deposits
11101.28.2 Unsecured wholesale deposits
11201.28.3 Secured funding
11301.29 29 Total funding
11401.29.1 Retail deposits
11501.29.2 Unsecured wholesale deposits
11601.29.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
10501.27 27 Total funding
10601.27.1 Retail deposits
10701.27.2 Unsecured wholesale deposits
10801.27.3 Secured funding
10901.28 28 Total funding
11001.28.1 Retail deposits
11101.28.2 Unsecured wholesale deposits
11201.28.3 Secured funding
11301.29 29 Total funding
11401.29.1 Retail deposits
11501.29.2 Unsecured wholesale deposits
11601.29.3 Secured funding
Roll-over of funding
Overnight > 1 day ≤ 7 days >7days ≤ 14 days
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item010020030040050060070080090100110120
11701.30 30 Total funding
11801.30.1 Retail deposits
11901.30.2 Unsecured wholesale deposits
12001.30.3 Secured funding
12101.31 31 Total funding
12201.31.1 Retail deposits
12301.31.2 Unsecured wholesale deposits
12401.31.3 Secured funding
Roll-over of funding
>14 days ≤ 1 month >1 Month ≤ 3 Months >3 Months ≤ 6 Months
Maturing Roll over New Funds Net Maturing Roll over New Funds Net Maturing Roll over New Funds Net
Row ID Day Item130140150160170180190200210220230240
11701.30 30 Total funding
11801.30.1 Retail deposits
11901.30.2 Unsecured wholesale deposits
12001.30.3 Secured funding
12101.31 31 Total funding
12201.31.1 Retail deposits
12301.31.2 Unsecured wholesale deposits
12401.31.3 Secured funding
Roll-over of funding
>6 Months Total net cashflows Average Term (days)
Maturing Roll over New Funds Net Maturing Funds Term Roll-over Funds Term New Funds Term Total Funding Profile
Row ID Day Item250260270280290300310320330
11701.30 30 Total funding
11801.30.1 Retail deposits
11901.30.2 Unsecured wholesale deposits
12001.30.3 Secured funding
12101.31 31 Total funding
12201.31.1 Retail deposits
12301.31.2 Unsecured wholesale deposits
12401.31.3 Secured funding

ANNEX XIX INSTRUCTIONS FOR COMPLETING THE ADDITIONAL MONITORING TOOLS TEMPLATE OF ANNEX XVIII

1.Additional Monitoring ToolsU.K.

1.1.General remarksU.K.
1.The summary templates contained in Annex XVIII is designed to monitor an institution's liquidity risk that falls outside of the scope of the reports on Liquidity Coverage and Stable Funding.U.K.
1.2.Concentration of funding by counterparty (C 67.00)U.K.
1.This template seeks to collect information about the reporting institutions' concentration of funding by counterparty.U.K.
2.For the purpose of completing this template:U.K.
(a)

Institutions shall report the top ten largest counterparties or a group of connected clients according to Article 4(39) of Regulation (EC) No 575/2013 [CRR] from which funding obtained from each counterparty exceeds a threshold of 1 % of total liabilities in the sublines of section 1 of the template. Thus, the counterparty reported in item 1.01 shall be the largest amount of funding received from one counterparty which is above the 1 % threshold as at the reporting date; item 1.02 shall be the second largest above the 1 % threshold; and so on.

(b)

Institutions shall report the total of all other remaining liabilities in section 2.

(c)

The totals of section 1 and section 2 shall equal an institution's total liabilities as per its balance sheet reported under the financial reporting framework (FINREP).

3.For each counterparty, institutions shall record the following components:U.K.
(a)

counterparty name;

(b)

LEI code;

(c)

counterparty sector;

(d)

residence of the counterparty;

(e)

product type;

(f)

amount received;

(g)

weighted average initial maturity; and

(h)

weighted average residual maturity

These components are explained in more detail in the table below.

4.Where funding is obtained in more than one product type, the type reported shall be the product in which the largest proportion of funding was obtained. Separate information shall be reported to the competent authority explaining the breakdown of funding received for the top 5 products by product type.U.K.
5.Identification of the underlying holder of securities may be undertaken on a best efforts basis. Where an institution has information concerning the holder of securities (i.e. is the custodian bank) it should consider that amount for reporting the concentration of counterparties. When there is no information available on the holder of securities the corresponding amount does not have to be reported.U.K.
6.Instructions concerning specific columns:U.K.
ColumnLegal references and instructions
010
Counterparty Name

The name of each counterparty from which funding obtained exceeds 1 % of total liabilities shall be recorded in column 010 in descending order, that is, in order of size of funding obtained.

The counterparty name recorded shall be the legal entity title of the company from which the funding is derived including any company type references such as SA (Société anonyme in France), Plc. (public limited company in the UK), or AG (Aktiengesellschaft in Germany).

020
LEI Code

The legal entity identifier code of the counterparty.

030
Counterparty Sector

One sector shall be allocated to every counterparty on the basis of FINREP economic sector classes:

(i) Central Banks; (ii) General Governments; (iii) Credit institutions; (iv) Other financial corporations; (v) Non-financial corporations; (vi) households.

For groups of connected clients, no sector shall be reported.

040
Residence of Counterparty

ISO code 3166-1-alpha-2 of the country of incorporation of the counterparty shall be used (including pseudo-ISO codes for international organisations, available in the last edition of the Eurostat's “Balance of Payments Vademecum”).

For groups of connected clients, no country shall be reported.

050
Product Type

Counterparties reported in column 010 shall be assigned a product type, corresponding to the product issued in which the funding was received (or in which the largest proportion of funding was received for mixed product types) using the following codes indicated in bold:

  • UWF (unsecured wholesale funding obtained from financial customers including interbank money)

  • UWNF (unsecured wholesale funding obtained from non-financial customers)

  • REPO (funding obtained from repurchase agreements as defined in Article 4(1) (82) of CRR)

  • CB (funding obtained from covered bond issuance as defined in Article 129(4) or (5) of CRR OR Article 52(4) of Directive 2009/65/EC)

  • ABS (funding obtained from asset backed security issuance including asset backed commercial paper)

  • IGCP (funding obtained from intragroup counterparties)

060
Amount Received

The total amount of funding received from counterparties reported in column 010 shall be recorded in column 060.

070
Weighted average initial maturity

For the amount of funding received reported in column 060, from the counterparty reported in column 010, a weighted average initial maturity (in days) for that funding shall be recorded in column 070.

Weighted average initial maturity is the average initial maturity (in days) of the funding received from that counterparty based on the size of different amounts of funding received to total funding received.

For example:

1.

EUR 1 billion received from counterparty A with an initial maturity of 180 days.

2.

EUR 0,5 billion received from counterparty A with an initial maturity of 360 days.

Weighted average initial maturity = (EUR 1 billion/EUR 1,5 billion) * 180 days + (EUR 0,5 billion/EUR 1,5 billion) * 360 days

Weighted average initial maturity = 240 days

080
Weighted average residual maturity

For the amount of funding received reported in column 060, from the counterparty reported in column 010, a weighted average residual maturity (in days) for that funding shall be recorded in column 080.

Weighted average residual maturity is the average maturity (in days) of the funding received from that counterparty left based on the size of different amounts of funding received to total funding received.

For example:

1.

EUR 1 billion received from counterparty A with 60 days residual maturity left.

2.

EUR 0.5 billion received from counterparty A with 180 days residual maturity left.

Weighted average residual maturity = (EUR 1 billion/EUR 1,5 billion) * 60 days + (EUR 0,5 billion/EUR 1,5 billion) * 180 days

Weighted average residual maturity = 100 days

1.3.Concentration of funding by product type (C 68.00)U.K.
1.This template seeks to collect information about the reporting institutions' concentration of funding by product type, broken down into the following funding types:U.K.
1.

Retail funding;

(a)

Sight deposits;

(b)

Fixed term deposits less or equal than 30 days

(c)

Fixed term deposits greater than 30 days;

(i)

With a penalty for early withdrawal significantly greater than the loss of interest;

(ii)

Without a penalty for early withdrawal which is significantly greater than the loss of interest;

(d)

Savings accounts;

(i)

With a notice period for withdrawal greater than 30 days;

(ii)

Without a notice period for withdrawal which is greater than 30 days;

2.

Wholesale funding;

(a)

Unsecured wholesale funding;

(i)

of which financial customers

(ii)

of which non-financial customers

(iii)

of which from intra-group entities

(b)

Secured wholesale funding;

(i)

of which repurchase agreements

(ii)

of which covered bond issuance

(iii)

of which asset backed security issuance

(iv)

of which from intra-group entities

2.For the purpose of completing this template institutions shall report the total amount of funding received from each product category, which exceeds a threshold of 1 % of total liabilities.U.K.
3.For each product type, institutions shall record the following components:U.K.
(a)

total amount received;

(b)

amount covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country;

(c)

amount not covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country;

(d)

weighted average initial maturity; and

(e)

weighted average residual maturity.

These components are explained in more detail in the table below.

4.For the purpose of determining those product types from which funding obtained is greater than 1 % of total liabilities threshold, the currency is irrelevant.U.K.
5.Instructions concerning specific columns:U.K.
ColumnLegal references and instructions
010
Total amount received

Total amount of funding received for each of the product categories listed in the “Product name” column shall be reported in column 010 of the template in one combined reporting currency.

020
Amount covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country

Of the total amount of funding received for each of the product categories listed in the “Product name” column reported in column 010, the amount which is covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country.

Note: the amounts reported in column 020 and column 030, for each of the product categories listed in the “Product name” column, shall be equal to the total amount received reported in column 010.

030
Amount not covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country

Of the total amount of funding received for each of the product categories listed in the “Product name” column reported in column 010, the amount which is not covered by a Deposit Guarantee Scheme according to Directive 94/19/EC or an equivalent deposit guarantee scheme in a third country.

Note: the amounts reported in column 020 and column 030, for each of the product categories listed in the “Product name” column, shall be equal to the total amount received reported in column 010.

040
Weighted average initial maturity

For the amount of funding received reported in column 010, from the product categories listed in the “Product name” column, a weighted average initial maturity (in days) for that funding shall be recorded in column 040.

Weighted average initial maturity is the average initial maturity (in days) of the funding received from each and every counterparty as a result of the issuance of a specified product, to total funding received from the issuance of that product.

For example:

1.

EUR 1 billion received from counterparty A as a result of issuing product X with an initial maturity of 180 days.

2.

EUR 0,5 billion received from counterparty B as a result of issuing product X with an initial maturity of 360 days.

Weighted average initial maturity = (EUR 1 billion/EUR 1,5 billion) * 180 days + (EUR 0,5 billion/EUR 1,5 billion) * 360 days

Weighted average initial maturity = 240 days

050
Weighted average residual maturity

For the amount of funding received reported in column 010, from the product categories listed in the “Product name” column, a weighted average residual maturity (in days) for that funding shall be recorded in column 050.

Weighted average residual maturity is the average maturity (in days) left on the funding received from each and every counterparty as a result of the issuance of a specified product, to total funding received from the issuance of that product.

For example:

1.

EUR 1 billion received from counterparty A as a result of issuing product X with 60 days residual maturity left.

2.

EUR 0,5 billion received from counterparty B as a result of issuing product X with 180 days residual maturity left.

Weighted average residual maturity = (EUR 1 billion/EUR 1,5 billion) * 60 days + (EUR 0,5 billion/EUR 1,5 billion) * 180 days

Weighted average residual maturity = 100 days

1.4.Prices for Various Lengths of Funding (C 69.00)U.K.
1.This template seeks to collect information about the average transaction volume and prices paid by institutions for funding with the following maturities:U.K.
(a)

Overnight (columns 010 and 020)

(b)

1 week (columns 030 and 040)

(c)

1 month (columns 050 and 060)

(d)

3 months (columns 070 and 080)

(e)

6 months (columns 090 and 100)

(f)

1 year (columns 110 and 120)

(g)

2 years (columns 130 and 140)

(h)

5 years (columns 150 and 160)

(i)

10 years (columns 170 and 180)

2.For the purpose of determining the maturity of funding obtained, institutions shall ignore the period between trade date and settlement date, e.g. a three month liability settling in two weeks' time shall be reported in the 3 months maturity (columns 070 and 080).U.K.
3.The spread reported in the left hand column of each time bucket shall be one of the following:U.K.
1.

the spread payable by the firm for liabilities less than or equal to one year, if they were to have been swapped to the benchmark overnight index for the appropriate currency no later than close of business on the day of the transaction;

2.

the spread payable by the firm at issuance for liabilities greater than one year, were they to be swapped to the relevant benchmark overnight index for the appropriate currency which is three month EURIBOR for EUR or LIBOR for GBP and USD, no later than close of business on the day of the transaction.

4.Spread shall be reported in basis points (bp) and calculated on a weighted average basis. For example:U.K.
1.

EUR 1 billion of funding received or offered by counterparty A with a spread 200 bp above the prevailing EURIBOR rate.

2.

EUR 0,5 billion of funding received or offered by counterparty B with a spread 150 bp above the prevailing EURIBOR rate.

Weighted average spread = (EUR 1 billion/EUR 1,5 billion) * 200 bp + (EUR 0.5 billion/EUR 1,5 billion) * 150 bp

Weighted average spread = 183 bp

5.For the purposes of calculating the average spread payable, institutions shall calculate the total cost in the currency of issue ignoring any FX swap, but include any premium or discount and fees payable or receivable, taking as basis the term of any theoretical or actual interest rate swap matching the term of the liability. The spread is the liability rate minus the swap rate.U.K.
6.The net amount of funding obtained for the funding categories listed in the “Item” column shall be reported in the “volume” column of the applicable time bucket. For example, for the funding in point 4 above, this would be EUR 1 500 000.U.K.
7.Where there is nothing to report, spreads shall be left empty.U.K.
8.Instructions concerning specific rows:U.K.
RowLegal references and instructions
010
1 Total Funding

Total volume and weighted average spread of all funding obtained for the following lengths:

(a)

Overnight (columns 010 and 020)

(b)

1 week (columns 030 ad 040)

(c)

1 month (columns 050 and 060)

(d)

3 months (columns 070 and 080)

(e)

6 months (columns 090 and 100)

(f)

1 year (columns 110 and 120)

(g)

2 years (columns 130 and 140)

(h)

5 years (columns 150 and 160)

(i)

10 years (columns 170 and 180)

020
1.1 of which: Retail deposits

Of the total funding reported in item 1, the total volume and weighted average spread of retail deposits obtained.

030
1.2 of which: Unsecured wholesale deposits

Of the total funding in item 1, the total volume and weighted average spread of unsecured wholesale deposits obtained

040
1.3 of which: Secured funding

Of the total funding reported in item 1, the total volume and weighted average spread of secured funding obtained.

050
1.4 of which: Senior unsecured securities

Of the total funding reported in item 1, the total volume and weighted average spread of senior unsecured securities obtained.

060
1.5 of which: Covered bonds

Of the total funding reported in item 1, the total volume and weighted average spread of all covered bond issuance encumbering the institutions own assets.

070
1.6 of which: Asset backed securities including ABCP

Of the total funding reported in item 1, the total volume and weighted average spread of asset backed securities issued including asset backed commercial paper.

1.5.Roll-over of funding (C 70.00)U.K.
1.This template seeks to collect information about the volume of funds maturing and new funding obtained i.e. “roll-over of funding” on a daily basis over a monthly time horizon.U.K.
2.Institutions shall report the funding they have maturing in the following time buckets:U.K.
(a)

Overnight (columns 010 to 040)

(b)

Between 1 day and 7 days (columns 050 to 080)

(c)

Between 7 days and 14 days (columns 090 to 120)

(d)

Between 14 days and 1 month (columns 130 to 160)

(e)

Between 1 month and 3 months (columns 170 to 200)

(f)

Between 3 months and 6 months (columns 210 to 240)

(g)

Maturing greater than 6 months (columns 250 to 280)

3.For each time bucket as described in point 2 above, the amount maturing shall be reported in the left-hand column, the amount funds rolled over shall be reported in the “Roll over” column, new funds obtained shall be reported in the “New Funds” column and the net difference (i.e. new funds + roll over — maturing) shall be reported in the right-hand column.U.K.
4.Total net cashflows shall be reported in column 290 and shall equal the sum of all “Net” columns (i.e. 040 + 080 + 120 + 160 + 200 + 240 + 280).U.K.
5.The average term of funding (in days) for maturing term funds shall be reported in column 300.U.K.
6.The average term of funding (in days) of funds rolled over shall be reported in column 310U.K.
7.The average term of funding (in days) for new term funds shall be reported in column 320.U.K.
8.The average term of funding (in days) for the total funding profile shall be reported in column 330.U.K.
9.Instructions concerning specific rows:U.K.
ColumnLegal references and instructions
010 to 040
Overnight

The total amount of funding maturing on a daily basis shall be reported in column 010 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall beleft empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 020 of line item 1.1-1.31.

The total amount of new funding obtained on a daily basis shall be reported in column 030 of line item 1.1-1.31.

The net difference between maturing daily funding and new daily funding obtained shall be reported in column 040 of line item 1.1-1.31.

050 to 080
> 1 day ≤ 7 days

The total amount of funding maturing between one day and one week shall be reported in column 050 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 060 of line item 1.1-1.31.

The total amount of new funding obtained for a duration between one day and one week shall be reported in column 70 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 080 of line item 1.1-1.31.

090 to 120
> 7days ≤ 14 days

The total amount of funding maturing between one week and two weeks shall be reported in column 090 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 100 of line item 1.1-1.31.

The total amount of new funding obtained for a duration between one week and two weeks shall be reported in column 110 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 120 of line item 1.1-1.31.

130 to 160
> 14 days ≤ 1 month

The total amount of funding maturing between two weeks and one month shall be reported in column 130 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 140 of line item 1.1-1.31.

The total amount of new funding obtained for a duration between two weeks and one month shall be reported in column 150 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 160 of line item 1.1-1.31.

170 to 200
> 1 Month ≤ 3 Months

The total amount of funding maturing between one month and three months shall be reported in column 170 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 180 of line item 1.1-1.31.

The total amount of new funding obtained for a duration between one month and three months shall be reported in column 190 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 200 of line item 1.1-1.31.

210 to 240
> 3 Months ≤ 6 Months

The total amount of funding maturing between three months and six months shall be reported in column 210 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 220 of line item 1.1-1.31.

The total amount of new funding obtained for a duration between three months and six months shall be reported in column 230 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 240 of line item 1.1-1.31.

250 to 280
> 6 Months

The total amount of funding maturing beyond six months shall be reported in column 250 of line item 1.1-1.31. For months with less than 31 days, irrelevant lines shall be left empty.

The total amount of funding rolled-over on a daily basis shall be reported in column 260 of line item 1.1-1.31.

The total amount of new funding obtained for a duration beyond six months shall be reported in column 270 of line item 1.1-1.31.

The net difference between maturing funding and new funding obtained shall be reported in column 280 of line item 1.1-1.31.

290
Total net cash flows

The total net cash flows equal to the sum of all “Net” columns (i.e. 040 + 080 + 120 + 160 + 200 + 240 + 280) shall be reported in column 290.

300 to 330
Average Term (days)

The weighted average term (in days) of all funds maturing shall be reported in column 300. The weighted average term (in days) of all funds rolled over shall be reported in column 310, the weighted average term (in days) of all new funds shall be reported in column 320 and the weighted average term (in days) for the total funding profile shall be reported in column 330.

ANNEX XX ADDITIONAL LIQUIDITY MONITORING METRICS UNDER ARTICLE 415(3)(b) OF REGULATION (EU) No 575/2013

ALMM TEMPLATES
Template number Template code Name of the template /group of templates
CONCENTRATION OF COUNTERBALANCING CAPACITY TEMPLATES
71C 71.00CONCENTRATION OF COUNTERBALANCING CAPACITY BY ISSUER/COUNTERPARTY

C 71.00 — CONCENTRATION OF COUNTERBALANCING CAPACITY BY ISSUER/COUNTERPARTY

z-axisTotal and significant currencies

Concentration of counterbalancing capacity by issuer/counterparty
Issuer/Counterparty Name LEI code Issuer/Counterparty Sector Residence of Issuer/Counterparty Product Type Currency Credit quality step MtM value/nominal Collateral value CB-eligible
Row ID010020030040050060070080090
010
1. TOP TEN ISSUERS/COUNTERPARTIES
0201,01
0301,02
0401,03
0501,04
0601,05
0701,06
0801,07
0901,08
1001,09
1101,10
120
2. ALL OTHER ITEMS USED AS COUNTERBALANCING CAPACITY

ANNEX XXI INSTRUCTIONS FOR COMPLETING THE CONCENTRATION OF COUNTERBALANCING CAPACITY TEMPLATE (C 71.00) OF ANNEX XXII

Concentration of Counterbalancing Capacity by issuer/counterparty (CCC) (C 71.00) U.K.

This template seeks to collect information about the reporting institutions' concentration of counterbalancing capacity by the ten largest holdings of assets or liquidity lines granted to the institution for this purpose. Counterbalancing capacity represents the stock of unencumbered assets or other funding sources which are legally and practically available to the institution at the reporting date to cover potential funding gaps. Only outflows and inflows pursuant to contracts existing at the reporting date shall be reported.

ColumnLegal references and instructions
010
Issuer/Counterparty Name

The name of the top ten issuers/counterparties of unencumbered assets or undrawn committed liquidity lines granted to the institution shall be recorded in column 010 in a descending fashion. The largest item will be recorded in 1.01, the second in line item 1.02, and so on.

The issuer/counterparty name recorded shall be the legal entity title of the company which has issued the assets, or has granted the liquidity lines, including any company type references, e.g. SA (Société anonyme in France), Plc. (public limited company in the UK), or AG (Aktiengesellschaft in Germany) etc.

020
LEI code

The legal entity identifier code of the counterparty.

030
Issuer/Counterparty Sector

One sector shall be allocated to every counterparty on the basis of FINREP economic sector classes:

(i) Central Banks; (ii) General Governments; (iii) Credit institutions; (iv) Other financial corporations; (v) Non-financial corporations; (vi) Households.

For groups of connected clients, no sector shall be reported.

040
Residence of Issuer/Counterparty

ISO code 3166-1-alpha-2 of the country of incorporation of the counterparty shall be used (including pseudo-ISO codes for international organisations, available in the last edition of the Eurostat's “Balance of Payments Vademecum”).

For groups of connected clients, no country shall be reported.

050
Product Type

Issuers/Counterparties recorded in column 010 shall be assigned a product type corresponding to the product in which the asset is held or the liquidity stand-by facility has been received, using the following codes indicated in bold:

  • SrB (Senior Bond)

  • SubB (Subordinated Bond)

  • CP (Commercial Paper)

  • CB (Covered Bonds)

  • US (UCITS-security, i.e. financial instruments representing a share in or a security issued by an Undertaking for Collective Investments of transferable securities)

  • ABS (Asset Backed Security)

  • CrCl (Credit Claim)

  • Eq (Equity listed on a recognized exchange, not self-issued or issued by a financial institution)

  • Gold

  • LiqL (Undrawn committed liquidity line granted to the institution)

  • OPT (Other product type)

060
Currency

Issuers/counterparties recorded in column 010 shall be assigned a currency ISO code in column 060 corresponding to the denomination of the asset received or undrawn committed liquidity lines granted to the institution. The three-letter currency unit code according to ISO 4217 shall be reported.

070
Credit quality step

Issuers/counterparties recorded in column 010 shall be assigned the appropriate credit quality step according to REGULATION 575/2013, consistent with the items reported in the maturity ladder.

080
MtM value/nominal

The market value or fair value of the assets, or — if applicable — the nominal value of the undrawn liquidity line granted to the institution.

090
Collateral value CB-eligible

The collateral value according to the central bank rules for standing facilities for the specific assets if they are used as collateral against credit received from the central bank.

For assets denominated in a currency included in the ITS issued under Article 416(5) Regulation (EC) No 575/2013 as a currency with extremely narrow central bank eligibility, institutions shall leave this field blank.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources